Prostate cancer, the most commonly diagnosed cancer in U.S. males, displays a broad spectrum of clinical behavior from indolent to fatal. Our current tools for prognostication are crude at best, leaving patients and their doctors struggling to decide which tumors need treatment, and, if so, how aggressively they should be treated. New molecular genetic markers of prostate cancer prognosis, ideally derived from an improved understanding of the molecular underpinnings of prostate cancer, are desperately needed. We have identified 3 distinct subtypes of prostate cancer by comprehensive gene expression profiling that appear to be clinically relevant and that would not be predicted by traditional clinical and pathological parameters. From these expression profiles, we have identified genes correlated with these subtypes that provide independent prognostic information on patients after surgery. We propose to validate and expand this gene expression dataset to identify additional markers of prognosis. We will analyze tumor samples from patients who have recurred after surgery and compare their gene expression patterns to matched samples from patients who have not recurred. Prognostic markers will be identified from intrinsic features of the data (tumor subclasses) and from supervised and semi-supervised analyses of data from recurrent and nonrecurrent patients. We will also perform genome-wide analysis of DNA copy-number changes using microarray-based comparative genomic hybridization to evaluate the extent to which DNA changes contribute to or underlie the molecular subtypes of prostate cancer. Finally, the clinical significance of individual transcript alterations, their cognate proteins, or regions of DNA amplification or loss will be evaluated on tissue microarrays with associated detailed clinical data and long-term follow-up. The proposed work will help interpret our prostate cancer gene expression dataset and translate findings from this work into clinical practice.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA111782-03
Application #
7216307
Study Section
Cancer Biomarkers Study Section (CBSS)
Program Officer
Tricoli, James
Project Start
2005-07-08
Project End
2009-04-30
Budget Start
2007-05-01
Budget End
2008-04-30
Support Year
3
Fiscal Year
2007
Total Cost
$262,921
Indirect Cost
Name
Stanford University
Department
Urology
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Gulzar, Z G; McKenney, J K; Brooks, J D (2013) Increased expression of NuSAP in recurrent prostate cancer is mediated by E2F1. Oncogene 32:70-7
Yin, G; Alvero, A B; Craveiro, V et al. (2013) Constitutive proteasomal degradation of TWIST-1 in epithelial-ovarian cancer stem cells impacts differentiation and metastatic potential. Oncogene 32:39-49
Huang, S; Gulzar, Z G; Salari, K et al. (2012) Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness. Oncogene 31:4164-70
Kobayashi, Yuya; Absher, Devin M; Gulzar, Zulfiqar G et al. (2011) DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer. Genome Res 21:1017-27
Malhotra, Sameer; Lapointe, Jacques; Salari, Keyan et al. (2011) A tri-marker proliferation index predicts biochemical recurrence after surgery for prostate cancer. PLoS One 6:e20293
Holterhus, Paul-Martin; Bebermeier, Jan-Hendrik; Werner, Ralf et al. (2009) Disorders of sex development expose transcriptional autonomy of genetic sex and androgen-programmed hormonal sex in human blood leukocytes. BMC Genomics 10:292
King, Christopher R; Ferrari, Michelle; Brooks, James D (2009) Prognostic significance of prostate cancer originating from the transition zone. Urol Oncol 27:592-7
Bhamre, Suvarna; Sahoo, Debashis; Tibshirani, Robert et al. (2009) Temporal changes in gene expression induced by sulforaphane in human prostate cancer cells. Prostate 69:181-90
Zhao, Hongjuan; Zongming Ma; Tibshirani, Robert et al. (2009) Alteration of gene expression signatures of cortical differentiation and wound response in lethal clear cell renal cell carcinomas. PLoS One 4:e6039
Thompson, Maxwell; Lapointe, Jacques; Choi, Yoon-La et al. (2008) Identification of candidate prostate cancer genes through comparative expression-profiling of seminal vesicle. Prostate 68:1248-56

Showing the most recent 10 out of 13 publications